Loading…
Archean Chemical Industries (ACI)₹424.30−1.57%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Archean Chemical Industries reported sales of ₹298 Cr, up 27.5% from Sep 2025, and net profit of ₹31.03 Cr, up 6.9% year on year. For the year to Mar 2026, sales were ₹1,085 Cr and net profit ₹105 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 415 | 285 | 214 | 241 | 243 | 347 | 293 | 234 | 256 | 302 | 328 | 298 |
| Expenses | 268 | 198 | 141 | 167 | 162 | 258 | 215 | 172 | 201 | 258 | 261 | 228 |
| Operating Profit | 145 | 87.23 | 71.21 | 75.16 | 80.20 | 88.25 | 78.18 | 63.12 | 54.10 | 44.10 | 67.12 | 70.18 |
| OPM % | 35.0% | 31.0% | 33.0% | 31.0% | 33.0% | 26.0% | 27.0% | 27.0% | 21.0% | 15.0% | 21.0% | 24.0% |
| Other Income | 9.02 | 12.02 | 10.02 | −29.03 | 9.02 | 8.02 | 8.01 | 6.01 | 7.01 | 5.01 | 6.01 | 4.01 |
| Interest | 1.99 | 1.99 | 1.99 | 2.99 | 2.99 | 0.00 | 4.99 | 5.99 | 3.99 | 9.98 | 4.99 | 4.99 |
| Depreciation | 17.95 | 17.94 | 18.94 | 18.93 | 19.94 | 20.96 | 22.93 | 23.95 | 23.92 | 22.93 | 22.95 | 23.94 |
| Profit before tax | 135 | 79.75 | 60.80 | 22.93 | 65.77 | 74.75 | 57.78 | 39.89 | 32.88 | 15.95 | 43.87 | 45.84 |
| Tax % | 25.1% | 28.0% | 26.1% | 31.1% | 27.1% | 28.1% | 31.0% | 27.0% | 28.0% | 23.1% | 31.0% | 32.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | −32.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 102 | 58.06 | 45.07 | 16.02 | 48.06 | 54.08 | 40.05 | 29.03 | 24.04 | 12.02 | 30.06 | 31.03 |
| EPS (Rs) | 8.22 | 4.66 | 3.63 | 1.27 | 3.88 | 4.33 | 3.25 | 2.35 | 1.90 | 1.08 | 2.48 | 2.59 |
| Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 610 | 1,134 | 1,446 | 1,334 | 1,045 | 1,085 | 1,184 |
| Expenses | 461 | 665 | 809 | 870 | 728 | 844 | 947 |
| Operating Profit | 148 | 468 | 635 | 464 | 316 | 240 | 236 |
| OPM % | 24.0% | 41.0% | 44.0% | 35.0% | 30.0% | 22.0% | 19.9% |
| Other Income | 9.02 | 12.02 | 43.08 | 43.06 | −3.01 | 27.06 | 22.04 |
| Interest | 122 | 162 | 96.77 | 7.98 | 7.98 | 25.95 | 23.95 |
| Depreciation | 51.84 | 66.85 | 68.76 | 69.78 | 78.84 | 92.71 | 93.74 |
| Profit before tax | −16.96 | 250 | 510 | 426 | 223 | 147 | 139 |
| Tax % | 117.0% | 25.0% | 25.1% | 25.0% | 28.1% | 28.1% | — |
| Exceptional items | 0.00 | 0.99 | 2.99 | 16.94 | −12.94 | 3.99 | 0.00 |
| Net Profit | −36.08 | 188 | 384 | 319 | 162 | 105 | 97.15 |
| EPS (Rs) | −3.75 | 19.51 | 31.08 | 25.83 | 13.13 | 8.65 | 8.05 |
| Dividend payout % | 0.0% | 0.0% | 8.1% | 12.1% | 23.1% | 29.1% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 19.04 | 24.99 | 25.00 | 25.02 | 25.01 |
| Reserves | 243 | 1,406 | 1,678 | 1,839 | 1,910 |
| Borrowings | 896 | 68.84 | 97.85 | 235 | 465 |
| Other Liabilities | 371 | 254 | 254 | 289 | 263 |
| Total Liabilities | 1,530 | 1,754 | 2,055 | 2,388 | 2,662 |
| Fixed Assets | 1,085 | 1,108 | 1,159 | 1,376 | 1,380 |
| CWIP | 16.98 | 35.93 | 47.95 | 68.87 | 182 |
| Investments | 11.04 | 211 | 351 | 340 | 258 |
| Other Assets | 417 | 399 | 497 | 603 | 843 |
| Inventories | 121 | 168 | 127 | 168 | 216 |
| Trade receivables | 153 | 118 | 156 | 165 | 127 |
| Cash & equivalents | 58.95 | 32.98 | 45.01 | 53.02 | 54.97 |
| Total Assets | 1,530 | 1,754 | 2,055 | 2,388 | 2,662 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 315 | 496 | 379 | 176 | 140 |
| Cash from investing activity | −110 | −291 | −308 | −247 | −294 |
| Cash from financing activity | −224 | −212 | −32.94 | 64.89 | 154 |
| Net cash flow | −19.02 | −6.01 | 40.04 | −5.01 | 1.01 |
| Capex | 97.39 | 100 | 131 | 265 | 384 |
| Free cash flow | 218 | 397 | 249 | −81.09 | −242 |
| CFO / OP % | 67.1% | 82.1% | 106.1% | 73.1% | 83.1% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 48 | 29 | 42 | 57 | 42 |
| Inventory days | — | — | 529 | — | 1,220 |
| Days payable | — | — | 416 | — | 598 |
| Cash conversion cycle | 48 | 29 | 156 | 57 | 665 |
| Working capital days | 49 | 41 | 54 | 84 | 11 |
| ROCE % | — | 45.0% | 25.0% | 13.0% | 7.0% |
For the Sep 2026 quarter, Archean Chemical Industries reported sales of ₹298 Cr, up 27.5% year on year and net profit of ₹31.03 Cr, up 6.9% year on year. The operating margin was 24.0%.
Archean Chemical Industries' sales for the year to Mar 2026 were ₹1,085 Cr; over the last twelve months they were ₹1,184 Cr.
Net profit for the year to Mar 2026 was ₹105 Cr, and ₹97.15 Cr over the last twelve months. Earnings per share over the same trailing period were ₹8.05.
Archean Chemical Industries reported borrowings of ₹465 Cr at Mar 2026, against cash and equivalents of ₹54.97 Cr.
Cash from operations was ₹140 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹242 Cr.